Orgenesis Inc. (ORGS): Price and Financial Metrics
Orgenesis Inc. (ORGS)
Today's Latest Price: $4.95 USD
Updated Nov 27 1:00pm
Add ORGS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ORGS Stock Summary
- ORGS's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.52 -- higher than only 6.33% of US-listed equities with positive expected earnings growth.
- With a year-over-year growth in debt of -41.92%, Orgenesis Inc's debt growth rate surpasses only 7.43% of about US stocks.
- As for revenue growth, note that ORGS's revenue has grown -48.14% over the past 12 months; that beats the revenue growth of merely 5.53% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Orgenesis Inc are AMBA, CVM, WATT, IPHI, and CUE.
- ORGS's SEC filings can be seen here. And to visit Orgenesis Inc's official web site, go to www.orgenesis.com.
ORGS Stock Price Chart Interactive Chart >
ORGS Price/Volume Stats
| Current price | $4.95 | 52-week high | $8.20 |
| Prev. close | $4.86 | 52-week low | $2.35 |
| Day low | $4.88 | Volume | 13,000 |
| Day high | $4.99 | Avg. volume | 83,883 |
| 50-day MA | $4.93 | Dividend yield | N/A |
| 200-day MA | $5.26 | Market Cap | 119.57M |
Orgenesis Inc. (ORGS) Company Bio
Orgenesis Inc., a service and research company, focus on the development and manufacture of cell therapy for advanced medicinal products in the field of regenerative medicine industry. The company was founded in 2008 and is based in Germantown, Maryland.
Loading social stream, please wait...